Alisporivir (DEB025)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alisporivir (DEB025), covering 2016-08-25 to 2016-08-25. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment [Phase 2]